Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

2.

Misappropriation of medications and equipment in the emergency department.

Hendarto A, Harding AM, Kant JA, Hunter MT, Taylor DM.

Australas Emerg Care. 2019 Jun;22(2):92-96. doi: 10.1016/j.auec.2019.01.005. Epub 2019 Feb 21.

PMID:
31042528
3.

Barriers to providing optimal management of psychiatric patients in the emergency department (psychiatric patient management).

Dombagolla MHK, Kant JA, Lai FWY, Hendarto A, Taylor DM.

Australas Emerg Care. 2019 Mar;22(1):8-12. doi: 10.1016/j.auec.2019.01.001. Epub 2019 Jan 29.

PMID:
30998873
4.

Our observations with cold calling: Patient anger and undesirable experiences.

Taylor DM, Kant JA, Dombagolla MH, Lai FW, Hendarto A.

Emerg Med Australas. 2019 Apr;31(2):283-286. doi: 10.1111/1742-6723.13258. Epub 2019 Feb 19.

PMID:
30780201
5.

Variables associated with completeness of medical record documentation in the emergency department.

Lai FW, Kant JA, Dombagolla MH, Hendarto A, Ugoni A, Taylor DM.

Emerg Med Australas. 2019 Aug;31(4):632-638. doi: 10.1111/1742-6723.13229. Epub 2019 Jan 28.

PMID:
30690885
6.

Multilab EcoFAB study shows highly reproducible physiology and depletion of soil metabolites by a model grass.

Sasse J, Kant J, Cole BJ, Klein AP, Arsova B, Schlaepfer P, Gao J, Lewald K, Zhalnina K, Kosina S, Bowen BP, Treen D, Vogel J, Visel A, Watt M, Dangl JL, Northen TR.

New Phytol. 2019 Apr;222(2):1149-1160. doi: 10.1111/nph.15662. Epub 2019 Jan 24.

7.

Identifying and predicting distinct distress trajectories following a breast cancer diagnosis - from treatment into early survival.

Kant J, Czisch A, Schott S, Siewerdt-Werner D, Birkenfeld F, Keller M.

J Psychosom Res. 2018 Dec;115:6-13. doi: 10.1016/j.jpsychores.2018.09.012. Epub 2018 Oct 1.

PMID:
30470319
8.

Analgesia in the emergency department: why is it not administered?

Kant J, Dombagolla M, Lai F, Hendarto A, Taylor DM.

Emerg Med J. 2019 Jan;36(1):12-17. doi: 10.1136/emermed-2018-207629. Epub 2018 Oct 30.

PMID:
30377161
9.

Dr Google in the ED: searching for online health information by adult emergency department patients.

Cocco AM, Zordan R, Taylor DM, Weiland TJ, Dilley SJ, Kant J, Dombagolla M, Hendarto A, Lai F, Hutton J.

Med J Aust. 2018 Oct 15;209(8):342-347. Epub 2018 Aug 20.

PMID:
30107763
10.

Microencephaly in fetal piglets following in utero inoculation of Zika virus.

Wichgers Schreur PJ, van Keulen L, Anjema D, Kant J, Kortekaas J.

Emerg Microbes Infect. 2018 Mar 29;7(1):42. doi: 10.1038/s41426-018-0044-y.

11.

Investigating cell-type specific functions of tenascin-C.

Murdamoothoo D, Schwenzer A, Kant J, Rupp T, Marzeda A, Midwood K, Orend G.

Methods Cell Biol. 2018;143:401-428. doi: 10.1016/bs.mcb.2017.08.023. Epub 2017 Dec 1.

PMID:
29310789
12.

A novel highly sensitive, rapid and safe Rift Valley fever virus neutralization test.

Wichgers Schreur PJ, Paweska JT, Kant J, Kortekaas J.

J Virol Methods. 2017 Oct;248:26-30. doi: 10.1016/j.jviromet.2017.06.001. Epub 2017 Jun 3.

13.

Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.

Wichgers Schreur PJ, van Keulen L, Kant J, Kortekaas J.

Vaccine. 2017 May 25;35(23):3123-3128. doi: 10.1016/j.vaccine.2017.04.024. Epub 2017 Apr 27.

14.

HBsAg and anti-HCV screening in elderly hospitalized patients of a German tertiary referral centre.

Kant J, Kratzsch J, Maier M, Liebert UG, Berg T, Wiegand J.

Z Gastroenterol. 2016 Mar;54(3):231-7. doi: 10.1055/s-0041-106656. Epub 2016 Apr 4.

PMID:
27043886
15.

Co-housing of Rift Valley Fever Virus Infected Lambs with Immunocompetent or Immunosuppressed Lambs Does Not Result in Virus Transmission.

Wichgers Schreur PJ, van Keulen L, Kant J, Oreshkova N, Moormann RJ, Kortekaas J.

Front Microbiol. 2016 Mar 7;7:287. doi: 10.3389/fmicb.2016.00287. eCollection 2016.

16.

Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.

Wichgers Schreur PJ, Kant J, van Keulen L, Moormann RJ, Kortekaas J.

Vaccine. 2015 Mar 17;33(12):1459-64. doi: 10.1016/j.vaccine.2015.01.077. Epub 2015 Feb 7.

PMID:
25665959
17.

Comparative efficacy of two next-generation Rift Valley fever vaccines.

Kortekaas J, Oreshkova N, van Keulen L, Kant J, Bosch BJ, Bouloy M, Moulin V, Goovaerts D, Moormann RJ.

Vaccine. 2014 Sep 3;32(39):4901-8. doi: 10.1016/j.vaccine.2014.07.037. Epub 2014 Jul 19.

PMID:
25050973
18.

The business of genomic testing: a survey of early adopters.

Crawford JM, Bry L, Pfeifer J, Caughron SK, Black-Schaffer S, Kant JA, Kaufman JH.

Genet Med. 2014 Dec;16(12):954-61. doi: 10.1038/gim.2014.60. Epub 2014 Jul 10.

19.

The histopathology of PRSS1 hereditary pancreatitis.

Singhi AD, Pai RK, Kant JA, Bartholow TL, Zeh HJ, Lee KK, Wijkstrom M, Yadav D, Bottino R, Brand RE, Chennat JS, Lowe ME, Papachristou GI, Slivka A, Whitcomb DC, Humar A.

Am J Surg Pathol. 2014 Mar;38(3):346-53. doi: 10.1097/PAS.0000000000000164.

20.

A single vaccination with an improved nonspreading Rift Valley fever virus vaccine provides sterile immunity in lambs.

Oreshkova N, van Keulen L, Kant J, Moormann RJ, Kortekaas J.

PLoS One. 2013 Oct 22;8(10):e77461. doi: 10.1371/journal.pone.0077461. eCollection 2013.

21.

Dietary long chain n-3 polyunsaturated fatty acids prevent allergic sensitization to cow's milk protein in mice.

van den Elsen LW, van Esch BC, Hofman GA, Kant J, van de Heijning BJ, Garssen J, Willemsen LE.

Clin Exp Allergy. 2013 Jul;43(7):798-810. doi: 10.1111/cea.12111.

PMID:
23786286
22.

Vertical transmission of Rift Valley fever virus without detectable maternal viremia.

Antonis AF, Kortekaas J, Kant J, Vloet RP, Vogel-Brink A, Stockhofe N, Moormann RJ.

Vector Borne Zoonotic Dis. 2013 Aug;13(8):601-6. doi: 10.1089/vbz.2012.1160. Epub 2013 May 19.

PMID:
23682700
23.

Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics.

Gullapalli RR, Desai KV, Santana-Santos L, Kant JA, Becich MJ.

J Pathol Inform. 2012;3:40. doi: 10.4103/2153-3539.103013. Epub 2012 Oct 31.

24.

Evaluation of a rapid on-site anti-HCV test as a screening tool for hepatitis C virus infection.

Kant J, Möller B, Heyne R, Herber A, Böhm S, Maier M, Liebert UG, Mössner J, Berg T, Wiegand J.

Eur J Gastroenterol Hepatol. 2013 Apr;25(4):416-20. doi: 10.1097/MEG.0b013e32835c502d.

PMID:
23211286
25.

Investigation of the hepatic glucuronidation pattern of the Fusarium mycotoxin deoxynivalenol in various species.

Maul R, Warth B, Kant JS, Schebb NH, Krska R, Koch M, Sulyok M.

Chem Res Toxicol. 2012 Dec 17;25(12):2715-7. doi: 10.1021/tx300348x. Epub 2012 Nov 14.

PMID:
23106612
26.

European ring trial to evaluate ELISAs for the diagnosis of infection with Rift Valley fever virus.

Kortekaas J, Kant J, Vloet R, Cêtre-Sossah C, Marianneau P, Lacote S, Banyard AC, Jeffries C, Eiden M, Groschup M, Jäckel S, Hevia E, Brun A.

J Virol Methods. 2013 Jan;187(1):177-81. doi: 10.1016/j.jviromet.2012.09.016. Epub 2012 Sep 26.

PMID:
23022325
27.

Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology.

Schrijver I, Aziz N, Farkas DH, Furtado M, Gonzalez AF, Greiner TC, Grody WW, Hambuch T, Kalman L, Kant JA, Klein RD, Leonard DG, Lubin IM, Mao R, Nagan N, Pratt VM, Sobel ME, Voelkerding KV, Gibson JS.

J Mol Diagn. 2012 Nov;14(6):525-40. doi: 10.1016/j.jmoldx.2012.04.006. Epub 2012 Aug 20.

28.

CD123 immunohistochemical expression in acute myeloid leukemia is associated with underlying FLT3-ITD and NPM1 mutations.

Rollins-Raval M, Pillai R, Warita K, Mitsuhashi-Warita T, Mehta R, Boyiadzis M, Djokic M, Kant JA, Roth CG.

Appl Immunohistochem Mol Morphol. 2013 May;21(3):212-7. doi: 10.1097/PAI.0b013e318261a342.

PMID:
22914610
29.

Efficacy of three candidate Rift Valley fever vaccines in sheep.

Kortekaas J, Antonis AF, Kant J, Vloet RP, Vogel A, Oreshkova N, de Boer SM, Bosch BJ, Moormann RJ.

Vaccine. 2012 May 14;30(23):3423-9. doi: 10.1016/j.vaccine.2012.03.027. Epub 2012 Mar 24.

PMID:
22449427
30.

Design and analytical validation of clinical DNA sequencing assays.

Pont-Kingdon G, Gedge F, Wooderchak-Donahue W, Schrijver I, Weck KE, Kant JA, Oglesbee D, Bayrak-Toydemir P, Lyon E; Biochemical and Molecular Genetic Resource Committee of the College of American Pathologists.

Arch Pathol Lab Med. 2012 Jan;136(1):41-6. doi: 10.5858/arpa.2010-0623-OA.

PMID:
22208486
31.

Verification of performance specifications of a molecular test: cystic fibrosis carrier testing using the Luminex liquid bead array.

Lacbawan FL, Weck KE, Kant JA, Feldman GL, Schrijver I; Biological and Molecular Genetic Resource Committee of the College of American Pathologists.

Arch Pathol Lab Med. 2012 Jan;136(1):14-9. doi: 10.5858/arpa.2010-0536-OA.

PMID:
22208482
32.

Recalcitrance of bacterial vaginosis among herpes-simplex-virus-type-2-seropositive women.

Stoner KA, Reighard SD, Vicetti Miguel RD, Landsittel D, Cosentino LA, Kant JA, Cherpes TL.

J Obstet Gynaecol Res. 2012 Jan;38(1):77-83. doi: 10.1111/j.1447-0756.2011.01697.x. Epub 2011 Dec 5.

33.

VP-1 quasispecies in human infection with polyomavirus BK.

Luo C, Hirsch HH, Kant J, Randhawa P.

J Med Virol. 2012 Jan;84(1):152-61. doi: 10.1002/jmv.22147. Epub 2011 Nov 3.

34.

Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease research.

Vicetti Miguel RD, Chivukula M, Krishnamurti U, Amortegui AJ, Kant JA, Sweet RL, Wiesenfeld HC, Phillips JM, Cherpes TL.

Pathol Res Pract. 2011 Nov 15;207(11):680-5. doi: 10.1016/j.prp.2011.08.007. Epub 2011 Oct 13.

35.

Impact of genomic sequence variability on quantitative PCR assays for diagnosis of polyomavirus BK infection.

Randhawa P, Kant J, Shapiro R, Tan H, Basu A, Luo C.

J Clin Microbiol. 2011 Dec;49(12):4072-6. doi: 10.1128/JCM.01230-11. Epub 2011 Sep 28.

36.

Clonal T-cell receptor β-chain gene rearrangements in differential diagnosis of lymphomatoid papulosis from skin metastasis of nodal anaplastic large-cell lymphoma.

Akilov OE, Pillai RK, Grandinetti LM, Kant JA, Geskin L.

Arch Dermatol. 2011 Aug;147(8):943-7. doi: 10.1001/archdermatol.2011.187. Erratum in: Arch Dermatol. 2012 Oct;148(10):1218.

37.

Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets.

Edinger JT, Kant JA, Swerdlow SH.

Am J Surg Pathol. 2010 Dec;34(12):1830-41. doi: 10.1097/PAS.0b013e3181f72835.

PMID:
21107089
38.

Characterization of new ACADSB gene sequence mutations and clinical implications in patients with 2-methylbutyrylglycinuria identified by newborn screening.

Alfardan J, Mohsen AW, Copeland S, Ellison J, Keppen-Davis L, Rohrbach M, Powell BR, Gillis J, Matern D, Kant J, Vockley J.

Mol Genet Metab. 2010 Aug;100(4):333-8. doi: 10.1016/j.ymgme.2010.04.014. Epub 2010 May 23.

39.

Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.

Kortekaas J, de Boer SM, Kant J, Vloet RP, Antonis AF, Moormann RJ.

Vaccine. 2010 Jun 17;28(27):4394-401. doi: 10.1016/j.vaccine.2010.04.048. Epub 2010 Apr 29.

PMID:
20434545
40.

Global gene profiling and comprehensive bioinformatics analysis of a 46,XY female with pericentric inversion of the Y chromosome.

Mitsuhashi T, Warita K, Tabuchi Y, Takasaki I, Kondo T, Sugawara T, Hayashi F, Wang ZY, Matsumoto Y, Miki T, Takeuchi Y, Ebina Y, Yamada H, Sakuragi N, Yokoyama T, Nanmori T, Kitagawa H, Kant JA, Hoshi N.

Congenit Anom (Kyoto). 2010 Mar;50(1):40-51. doi: 10.1111/j.1741-4520.2009.00254.x.

PMID:
20201967
41.

Epigenetic abnormality of SRY gene in the adult XY female with pericentric inversion of the Y chromosome.

Mitsuhashi T, Warita K, Sugawara T, Tabuchi Y, Takasaki I, Kondo T, Hayashi F, Wang ZY, Matsumoto Y, Miki T, Takeuchi Y, Ebina Y, Yamada H, Sakuragi N, Yokoyama T, Nanmori T, Kitagawa H, Kant JA, Hoshi N.

Congenit Anom (Kyoto). 2010 Jun;50(2):85-94. doi: 10.1111/j.1741-4520.2010.00274.x. Epub 2010 Feb 22.

PMID:
20184645
42.

Array-based karyotyping for prognostic assessment in chronic lymphocytic leukemia: performance comparison of Affymetrix 10K2.0, 250K Nsp, and SNP6.0 arrays.

Hagenkord JM, Monzon FA, Kash SF, Lilleberg S, Xie Q, Kant JA.

J Mol Diagn. 2010 Mar;12(2):184-96. doi: 10.2353/jmoldx.2010.090118. Epub 2010 Jan 14.

43.

Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.

de Boer SM, Kortekaas J, Antonis AF, Kant J, van Oploo JL, Rottier PJ, Moormann RJ, Bosch BJ.

Vaccine. 2010 Mar 8;28(11):2330-9. doi: 10.1016/j.vaccine.2009.12.062. Epub 2010 Jan 5.

PMID:
20056185
44.

Identification of ATP citrate lyase as a positive regulator of glycolytic function in glioblastomas.

Beckner ME, Fellows-Mayle W, Zhang Z, Agostino NR, Kant JA, Day BW, Pollack IF.

Int J Cancer. 2010 May 15;126(10):2282-95. doi: 10.1002/ijc.24918.

45.

Development and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.

Barker SD, Bale S, Booker J, Buller A, Das S, Friedman K, Godwin AK, Grody WW, Highsmith E, Kant JA, Lyon E, Mao R, Monaghan KG, Payne DA, Pratt VM, Schrijver I, Shrimpton AE, Spector E, Telatar M, Toji L, Weck K, Zehnbauer B, Kalman LV.

J Mol Diagn. 2009 Nov;11(6):553-61. doi: 10.2353/jmoldx.2009.090078. Epub 2009 Sep 18.

46.

Loss of heterozygosity of succinate dehydrogenase B mutation by direct sequencing in synchronous paragangliomas.

Prasad P, Kant JA, Wills M, O'Leary M, Lovvorn H 3rd, Yang E.

Cancer Genet Cytogenet. 2009 Jul 15;192(2):82-5. doi: 10.1016/j.cancergencyto.2009.04.009.

47.

Human Merkel cell polyomavirus infection I. MCV T antigen expression in Merkel cell carcinoma, lymphoid tissues and lymphoid tumors.

Shuda M, Arora R, Kwun HJ, Feng H, Sarid R, Fernández-Figueras MT, Tolstov Y, Gjoerup O, Mansukhani MM, Swerdlow SH, Chaudhary PM, Kirkwood JM, Nalesnik MA, Kant JA, Weiss LM, Moore PS, Chang Y.

Int J Cancer. 2009 Sep 15;125(6):1243-9. doi: 10.1002/ijc.24510.

48.

Long-term outcome following Intensive Residential Treatment of Obsessive-Compulsive Disorder.

Stewart SE, Stack DE, Tsilker S, Alosso J, Stephansky M, Hezel DM, Jenike EA, Haddad SA, Kant J, Jenike MA.

J Psychiatr Res. 2009 Sep;43(13):1118-23. doi: 10.1016/j.jpsychires.2009.03.012. Epub 2009 May 5.

PMID:
19419736
49.

Genotyping schemes for polyomavirus BK, using gene-specific phylogenetic trees and single nucleotide polymorphism analysis.

Luo C, Bueno M, Kant J, Martinson J, Randhawa P.

J Virol. 2009 Mar;83(5):2285-97. doi: 10.1128/JVI.02180-08. Epub 2008 Dec 24.

50.

Phase II trial of short-course CHOP-R followed by 90Y-ibritumomab tiuxetan and extended rituximab in previously untreated follicular lymphoma.

Jacobs SA, Swerdlow SH, Kant J, Foon KA, Jankowitz R, Land SR, DeMonaco N, Joyce J, Osborn JL, Evans TL, Schaefer PM, Luong TM.

Clin Cancer Res. 2008 Nov 1;14(21):7088-94. doi: 10.1158/1078-0432.CCR-08-0529.

Supplemental Content

Support Center